CD4 and pneumocystosis: Our goal was to perform a systematic review of the published studies to determine the incidence of PCP in HIV-infected individuals with fully-suppressed plasma VL on antiretroviral therapy who discontinued PCP prophylaxis with CD4 count <200 cells/μL.